Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 11/20 | 0.70 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.67 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Albuterol SCHEMBL7775807 | 1.00 | ADRB2 (0.70) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Albuterol SCHEMBL7778379 | 1.00 | ADRB2 (0.70) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Stearic Acid SCHEMBL518159 | 0.95 | PMP22 (0.73) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Oleic Acid SCHEMBL6258016 | 0.94 | ADRB2 (0.62) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Stearic Acid SCHEMBL518158 | 0.86 | PMP22 (0.72) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Albuterol SCHEMBL6264324 | 0.86 | ADRB2 (0.65) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Albuterol SCHEMBL6838948 | 0.85 | ADRB2 (0.87) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Albuterol SCHEMBL4913 | 0.84 | ADRB2 (1.00) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Albuterol SCHEMBL121596 | 0.84 | ADRB2 (1.00) | ADRB2ADRB1CYP1A2CYP2D6TSHR | |
| Levosalbutamol SCHEMBL4003 | 0.84 | ADRB2 (1.00) | ADRB2ADRB1CYP1A2CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2001508027-A | — | — | 2001-06-19 | — | — | JP | claimed |
| EP-1024833-A1 | Pharmaceutical composition containing acid addition salt of basic drug | FARMARC NEDERLAND B.V. (NL) | 2000-08-09 | — | — | EP | claimed |
| CN-1230123-A | Inclusion complex containing indole selective serotonin agonist | FARMARC NEDERLAND BV (NL) | 1999-09-29 | — | — | CN | claimed |
| WO-1998002187-A1 | PHARMACEUTICAL COMPOSITION CONTAINING ACID ADDITION SALT OF BASIC DRUG | FARMARC NEDERLAND B.V. (NL) | 1998-01-22 | — | — | WO | claimed |
| US-20070053843-A1 | Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same | GLAXO GROUP LIMITED (GB) | 2007-03-08 | — | — | US | disclosed |
| EP-1686960-A4 | INHALABLE PHARMACEUTICAL FORMULATIONS EMPLOYING LACTOSE ANHYDRATE AND METHODS OF ADMINISTERING THE SAME | GLAXO GROUP LTD (GB) | 2007-03-07 | — | — | EP | disclosed |
| WO-2006124556-A2 | INHALABLE PHARMACEUTICAL FORMULATIONS EMPLOYING LACTOSE ANHYDRATE AND METHODS OF ADMINISTERING THE SAME | GLAXO GROUP LIMITED (GB) | 2006-11-23 | — | — | WO | disclosed |
| EP-1686960-A2 | INHALABLE PHARMACEUTICAL FORMULATIONS EMPLOYING LACTOSE ANHYDRATE AND METHODS OF ADMINISTERING THE SAME | GLAXO GROUP LIMITED (GB) | 2006-08-09 | — | — | EP | disclosed |
| EP-1588698-A2 | A process for the production and screening of materials for use in pharmaceutical aerosol formulations | Thompson, James Anthony (GB) | 2005-10-26 | — | — | EP | disclosed |
| WO-2005044186-A2 | INHALABLE PHARMACEUTICAL FORMULATIONS EMPLOYING DESICCATING AGENTS AND METHODS OF ADMINISTERING THE SAME | GLAXO GROUP LIMITED (GB) | 2005-05-19 | — | — | WO | disclosed |
| WO-2005044187-A2 | INHALABLE PHARMACEUTICAL FORMULATIONS EMPLOYING LACTOSE ANHYDRATE AND METHODS OF ADMINISTERING THE SAME | GLAXO GROUP LIMITED (GB) | 2005-05-19 | — | — | WO | disclosed |
| EP-1024833-A1 | Pharmaceutical composition containing acid addition salt of basic drug | FARMARC NEDERLAND B.V. (NL) | 2000-08-09 | — | — | EP | disclosed |
| CN-1230123-A | Inclusion complex containing indole selective serotonin agonist | FARMARC NEDERLAND BV (NL) | 1999-09-29 | — | — | CN | disclosed |
| WO-1998002187-A1 | PHARMACEUTICAL COMPOSITION CONTAINING ACID ADDITION SALT OF BASIC DRUG | FARMARC NEDERLAND B.V. (NL) | 1998-01-22 | — | — | WO | disclosed |